Atypical Antipsychotic
Pregnancy: C
Quetiapine (Elderly — Dementia Caution)
Brand names: Seroquel, Atrolak
Adult dose
Dose: 25–50 mg once or twice daily initially; increase slowly; dementia agitation: 25–50 mg/day
Route: oral
Frequency: once or twice daily
Max: 800 mg/day (schizophrenia); lower doses in elderly — start low, go slow
MHRA: increased risk of CVA and mortality in elderly with dementia — only use if other non-pharmacological measures failed; document consent
Paediatric dose
Route:
Not licensed for dementia-related psychosis in any age group; licensed for schizophrenia and bipolar in ≥13 years
Dose adjustments
Renal
No dose adjustment required
Hepatic
Reduce dose in hepatic impairment
Clinical pearls
- MHRA warning: antipsychotics for dementia-related psychosis increase mortality (1.6–1.7x) and stroke risk — document discussion with family
- CATIE trial: moderate efficacy for Alzheimer's psychosis — short-term use only with clear indication
- BEERS criteria: avoid in elderly if possible — alternatives include carer support, environmental modification
Contraindications
- Dementia with concurrent hepatic/renal impairment (cautious use)
- QT prolongation
- Concurrent potent CYP3A4 inhibitors
Side effects
- Sedation
- Orthostatic hypotension (falls)
- QT prolongation
- Metabolic syndrome (dyslipidaemia, hyperglycaemia)
- EPS (low)
- Anticholinergic effects
Interactions
- CYP3A4 inhibitors (ketoconazole — markedly increase levels)
- Antihypertensives (hypotension)
- QT-prolonging drugs
- Alcohol (CNS depression)
Monitoring
- ECG (QTc)
- FBC
- Glucose/HbA1c
- Lipids
- Blood pressure (postural)
- EPDS (falls assessment)
Reference: BNFc; BNF 86; MHRA guidance 2004; NICE NG97; CATIE trial. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Mini-Mental State Examination (MMSE) · Cognitive Assessment
- MoCA — Montreal Cognitive Assessment · Cognitive Assessment
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5